Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation

Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli. MAPK14 (p38α) affects major disease processes, while inhibition of p38α has been shown to have potential therapeutic effects. Many inhibitors targeting p38α have...

Full description

Bibliographic Details
Main Authors: Qinwen Zheng, Yumeng Zhu, Aoxue Wang, Panpan Yang, Xin Wang, Wen Shuai, Liang Ouyang, Guan Wang
Format: Article
Language:English
Published: Compuscript Ltd 2023-09-01
Series:Acta Materia Medica
Online Access:https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0028
_version_ 1797643809438302208
author Qinwen Zheng
Yumeng Zhu
Aoxue Wang
Panpan Yang
Xin Wang
Wen Shuai
Liang Ouyang
Guan Wang
author_facet Qinwen Zheng
Yumeng Zhu
Aoxue Wang
Panpan Yang
Xin Wang
Wen Shuai
Liang Ouyang
Guan Wang
author_sort Qinwen Zheng
collection DOAJ
description Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli. MAPK14 (p38α) affects major disease processes, while inhibition of p38α has been shown to have potential therapeutic effects. Many inhibitors targeting p38α have entered clinical trials but have a long development cycle and severe side effects. We developed a multi-step receptor structure-based virtual screening method to screen potential bioactive molecules from SPECS and our MCDB libraries. Compound 10 was identified as a promising p38α inhibitor that may be used in the treatment of p38αMAPK pathway-related diseases, but corollary studies are warranted.
first_indexed 2024-03-11T14:21:22Z
format Article
id doaj.art-80ccbd416aa3490d99958bc7850c9e2a
institution Directory Open Access Journal
issn 2737-7946
language English
last_indexed 2024-03-11T14:21:22Z
publishDate 2023-09-01
publisher Compuscript Ltd
record_format Article
series Acta Materia Medica
spelling doaj.art-80ccbd416aa3490d99958bc7850c9e2a2023-10-31T16:00:08ZengCompuscript LtdActa Materia Medica2737-79462023-09-012437738510.15212/AMM-2023-0028Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluationQinwen ZhengYumeng ZhuAoxue WangPanpan YangXin WangWen ShuaiLiang OuyangGuan WangMitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli. MAPK14 (p38α) affects major disease processes, while inhibition of p38α has been shown to have potential therapeutic effects. Many inhibitors targeting p38α have entered clinical trials but have a long development cycle and severe side effects. We developed a multi-step receptor structure-based virtual screening method to screen potential bioactive molecules from SPECS and our MCDB libraries. Compound 10 was identified as a promising p38α inhibitor that may be used in the treatment of p38αMAPK pathway-related diseases, but corollary studies are warranted.https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0028
spellingShingle Qinwen Zheng
Yumeng Zhu
Aoxue Wang
Panpan Yang
Xin Wang
Wen Shuai
Liang Ouyang
Guan Wang
Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation
Acta Materia Medica
title Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation
title_full Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation
title_fullStr Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation
title_full_unstemmed Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation
title_short Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation
title_sort structure based virtual screening for novel p38 mapk inhibitors and a biological evaluation
url https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0028
work_keys_str_mv AT qinwenzheng structurebasedvirtualscreeningfornovelp38mapkinhibitorsandabiologicalevaluation
AT yumengzhu structurebasedvirtualscreeningfornovelp38mapkinhibitorsandabiologicalevaluation
AT aoxuewang structurebasedvirtualscreeningfornovelp38mapkinhibitorsandabiologicalevaluation
AT panpanyang structurebasedvirtualscreeningfornovelp38mapkinhibitorsandabiologicalevaluation
AT xinwang structurebasedvirtualscreeningfornovelp38mapkinhibitorsandabiologicalevaluation
AT wenshuai structurebasedvirtualscreeningfornovelp38mapkinhibitorsandabiologicalevaluation
AT liangouyang structurebasedvirtualscreeningfornovelp38mapkinhibitorsandabiologicalevaluation
AT guanwang structurebasedvirtualscreeningfornovelp38mapkinhibitorsandabiologicalevaluation